Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

LGALS3 / Galectin 3

lectin, galactoside-binding, soluble, 3

LGALS3 / Galectin 3 is a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.

Gene Name: lectin, galactoside-binding, soluble, 3
Synonyms: LGALS3, 35 kd lectin, 35 kDa lectin, CBP35, GAL3, Galactoside-binding protein, GALIG, IgE-binding protein, Laminin-binding protein, Gal-3, GALBP, MAC-2, Mac-2 antigen, L31, MAC2, CBP 35, Galactose-specific lectin 3, Galectin-3, L-31, Lectin L-29
Target Sequences: NM_002306 NP_002297.2 P17931

Publications (8)

1
Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. Berger A, Mnk C, Schweizer M, Cichutek K, Schle S, Flory E. The Journal of biological chemistry. 2010 285:12248-54. [PubMed:20178977] [PMC:PMC2852964]
2
AlphaB-crystallin is found in detergent-resistant membrane microdomains and is secreted via exosomes from human retinal pigment epithelial cells. Gangalum RK, Atanasov IC, Zhou ZH, Bhat SP. The Journal of biological chemistry. 2011 286:3261-9. [PubMed:21097504] [PMC:PMC3030331]
3
FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL, Boileau C, Jondeau G, Prakash SK, Kwartler CS, Zhu LY, Peters AM, Duan XY, Bamshad MJ, Shendure J, Nickerson DA, Santos-Cortez RL, Dong X, Leal SM, Majesky MW, Swindell EC, Jamrich M, Milewicz DM. The Journal of clinical investigation. 2016 126:948-61. (WB; Mouse) [Full Text Article] [PubMed:26854927] [PMC:PMC4767350]
4
Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners. Gallardo-Vara E, Ruiz-Llorente L, Casado-Vela J, Ruiz-Rodríguez MJ, López-Andrés N, Pattnaik AK, Quintanilla M, Bernabeu C. Cells. 2019 September;8:E1082. [Full Text Article] [PubMed:31540324] [PMC:PMC6769930]
5
Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells. Shigemi Sasawatari, Yuki Okamoto, Atsushi Kumanogoh, Toshihiko Toyofuku. Journal of immunology (Baltimore, Md. : 1950). 2020 March;204:1373-1385. [Full Text Article] [PubMed:31969386] Related Antibodies: LS-C140105.
6
A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy. Umesh C Sharma, Swati D Sonkawade, Joseph A Spernyak, Sandra Sexton, Juliane Nguyen, Suraj Dahal, Kristopher M Attwood, Anurag K Singh, Jop H van Berlo, Saraswati Pokharel. Circulation. Heart failure. 2018 August;11:e004867. [Full Text Article] [PubMed:30354563] [PMC:PMC6205206]
7
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist. Brett E Phillips, Louise Lantier, Carl Engman, Yesica Garciafigueroa, Aatur Singhi, Massimo Trucco, Christos Mantzoros, David Wasserman, Nick Giannoukakis. Cardiovascular Diabetology. 2022 July;21:130. [Full Text Article] [PubMed:35831885] [PMC:PMC9277870]
8
Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks. Kyle E Korolowicz, Manasa Suresh, Bin Li, Xu Huang, Changsuek Yon, Bhaskar V Kallakury, Kyoung-Pil Lee, Sungman Park, Yoon-Won Kim, Stephan Menne. Cells. 2021 September;10:2321. [Full Text Article] [PubMed:34571970] [PMC:PMC8466705]
more

☰ Filters
Products
Proteins (25)
Over-Expression Lysate (2)
Recombinant (23)
LGALS3 / Galectin 3 (25)
No (23)
Yes (2)
6His, C-terminus (2)
6His, N-terminus (2)
GST (1)
His (6)
His, N-terminus + His, C-terminus (1)
His-GST (1)
Myc-DDK (Flag) (3)
Human (17)
Mouse (4)
Rabbit (1)
Rat (2)
293T Cells (1)
CHO Cells (1)
E. coli (16)
HEK 293 Cells (3)
Human Cells (1)
Mammalian Cells (1)
Wheat Germ Extract (1)
Purified (7)
Low endotoxin level (10)
Biologically active (7)
Select
E. coli
None
Biologically active
Less than 0.1 ng/µg of protein (less than 1EU/µg).
26.0 kDa
10 µg/$268; 50 µg/$349
LGALS3 / Galectin 3 Protein - Recombinant Galectin 3 By SDS-PAGE
Select
E. coli
His
28.4 kDa
10 µg/$278; 50 µg/$422; 100 µg/$672; 200 µg/$842; 1 mg/$1,934; 500 µg/$1,480; 5 mg/$2,941; 2 mg/$2,119
LGALS3 / Galectin 3 Protein
Select
E. coli
His
50 µg/$411; 250 µg/$985; 10 µg/$276
LGALS3 / Galectin 3 Protein
Select
E. coli
His
Biologically active
100 µg/$342; 500 µg/$641; 20 µg/$254
Select
Human Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
27.2kD
10 µg/$277; 50 µg/$395; 500 µg/$1,203; 1 mg/$1,627
LGALS3 / Galectin 3 Protein
Select
E. coli
6His, N-terminus
26 kDa
10 µg/$265; 50 µg/$315; 100 µg/$365
LGALS3 / Galectin 3 Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
E. coli
6His, N-terminus
31.1 kDa
1 mg/$1,679; 100 µg/$500; 20 µg/$364
LGALS3 / Galectin 3 Protein - Recombinant Mouse Galectin-3/Lgals3 protein (His Tag)
Select
E. coli
His, N-terminus + His, C-terminus
27.4kDa
20 µg/$270; 100 µg/$390
LGALS3 / Galectin 3 Protein - 12.5% SDS-PAGE of human LGALS3 stained with Coomassie Blue
Select
Wheat Germ Extract
GST
53.24 kDa
10 µg/$479; 25 µg/$670
LGALS3 / Galectin 3 Protein - Recombinant  Galectin 3 By SDS-PAGE
Select
E. coli
His-GST
55.4 kDa
10 µg/$286; 50 µg/$472; 100 µg/$752; 200 µg/$942; 1 mg/$2,069; 500 µg/$1,600; 5 mg/$3,291; 2 mg/$2,257
Select
None
Biologically active
26.0 kD
50 µg/$476
LGALS3 / Galectin 3 Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
26 kDa
20 µg/$150
LGALS3 / Galectin 3 Protein - Purified recombinant protein LGALS3 was analyzed by SDS-PAGE gel and Coomassie Blue Staining
Select
HEK 293 Cells
Myc-DDK (Flag)
26 kDa
20 µg/$1,107
LGALS3 / Galectin 3 Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
26 kDa
100 µg/$494
Select
E. coli
None
Less than 5.0 EU/mg protein (determined by LAL method).
26.1 kDa
20 µg/$360; 100 µg/$728
LGALS3 / Galectin 3 Protein
Select
E. coli
None
Biologically active
26.0 kDa
10 µg/$282; 100 µg/$503; 500 µg/$1,058
Select
E. coli
199 AA
His
Less than 0.1 EU/µg protein (determined by LAL method).
27.39 kDa
10 mg/$4,268; 5 mg/$3,201; 1 mg/$1,868; 0.5 mg/$1,475; 200 µg/$1,103; 100 µg/$756; 50 µg/$531
Select
CHO Cells
None
Biologically active
Less than 0.1 EU/µg protein (determined by LAL method).
The 270 amino acid recombinant protein has a predicted molecular mass of approximately 28.3 kD. The protein migrates above 40 kD by SDS-PAGE in DTT-reducing and non-reducing conditions. The predicted N-terminal amino acid is His.
25 µg/$306; 100 µg/$436
Select
HEK 293 Cells
None
Biologically active
Less than 0.1 EU/µg protein (determined by LAL method).
This 284 amino acid recombinant protein has a predicted molecular mass of approximately 29.5 kD. The protein migrates as above 45 kD in SDS-PAGE in DTT-reducing and non-reducing conditions. The predicted N-terminal amino acid is His.
25 µg/$306; 100 µg/$436
Select
E. coli
None
Less than 1.0 EU/µg protein (determined by LAL method).
26.0 kDa
10 µg/$248; 50 µg/$311
Select
Mammalian Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
27.2 kDa
10 µg/$277; 50 µg/$389
Select
E. coli
None
Less than 1.0 EU/µg protein (determined by LAL method).
26kD
10 µg/$248; 50 µg/$313; 500 µg/$743; 1 mg/$1,048
Select
E. coli
None
Biologically active
Less than 1.0 EU/µg protein (determined by LAL method).
~26.1 kDa
50 µg/$347; 1 mg/$2,041
LGALS3 / Galectin 3 Protein - Recombinant Galectin 3 By SDS-PAGE
Select
E. coli
His
27.4 kDa
10 µg/$259; 50 µg/$331; 100 µg/$482; 200 µg/$602; 1 mg/$1,553; 500 µg/$1,156; 5 mg/$2,481; 2 mg/$1,723
Select
E. coli
His
28.8 kDa
10 µg/$278; 50 µg/$422; 100 µg/$672; 200 µg/$842; 1 mg/$1,934; 500 µg/$1,480; 5 mg/$2,941; 2 mg/$2,119
Viewing 1-25 of 25 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).